BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30718860)

  • 1. Intraoperative but not postoperative blood transfusion adversely affect cancer recurrence and survival following nephrectomy for renal cell carcinoma.
    Abu-Ghanem Y; Dotan Z; Zilberman DE; Kaver I; Ramon J
    Sci Rep; 2019 Feb; 9(1):1160. PubMed ID: 30718860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative allogeneic blood transfusion is associated with adverse oncological outcomes in patients with surgically treated non-metastatic clear cell renal cell carcinoma.
    Kang HW; Seo SP; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Byun SS; Kim YJ;
    Int J Clin Oncol; 2020 Aug; 25(8):1551-1561. PubMed ID: 32504136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC).
    Linder BJ; Thompson RH; Leibovich BC; Cheville JC; Lohse CM; Gastineau DA; Boorjian SA
    BJU Int; 2014 Sep; 114(3):368-74. PubMed ID: 24471825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative blood transfusion adversely affects prognosis after nephrectomy for renal cell carcinoma.
    Abu-Ghanem Y; Zilberman DE; Dotan Z; Kaver I; Ramon J
    Urol Oncol; 2018 Jan; 36(1):12.e15-12.e20. PubMed ID: 28993059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of perioperative blood transfusion on oncologic outcomes in patients with nonmetastatic renal cell carcinoma treated with curative nephrectomy: A retrospective analysis of a large, single-institutional cohort.
    Seon DY; Kwak C; Kim HH; Ku JH; Kim HS
    Investig Clin Urol; 2020 Mar; 61(2):136-145. PubMed ID: 32158964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality?
    Abel EJ; Linder BJ; Bauman TM; Bauer RM; Thompson RH; Thapa P; Devon ON; Tarrell RF; Frank I; Jarrard DF; Downs TM; Boorjian SA
    Eur Urol; 2014 Dec; 66(6):1139-47. PubMed ID: 25194909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative Allogenic Blood Transfusion in Renal Cell Carcinoma: Risk Factors and Effect on Long-term Outcomes.
    Soria F; de Martino M; Leitner CV; Moschini M; Shariat SF; Klatte T
    Clin Genitourin Cancer; 2017 Jun; 15(3):e421-e427. PubMed ID: 28089722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of perioperative blood transfusion on prognosis after nephrectomy in patients with renal cell carcinoma: A meta-analysis and systematic review.
    Xu J; Bai J; Pan H; Zhou Z
    Medicine (Baltimore); 2024 Apr; 103(14):e37646. PubMed ID: 38579099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of blood transfusions on oncological outcomes of surgically treated localized renal cell carcinoma.
    Tsivian M; Abern MR; Tsivian E; Sze C; Jibara G; Rampersaud EN; Polascik TJ
    Urol Oncol; 2018 Aug; 36(8):362.e1-362.e7. PubMed ID: 29793797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
    Linder BJ; Frank I; Cheville JC; Tollefson MK; Thompson RH; Tarrell RF; Thapa P; Boorjian SA
    Eur Urol; 2013 May; 63(5):839-45. PubMed ID: 23332883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative Blood Transfusion Is a Predictor of Acute and Chronic Renal Function Deterioration after Partial and Radical Nephrectomy for Renal Cell Carcinoma.
    Mühlbauer J; de Gilde J; Mueller-Steinhardt M; Porubsky S; Walach M; Nuhn P; Klüter H; Wagener N; Kriegmair MC
    Urol Int; 2020; 104(9-10):775-780. PubMed ID: 32721964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative blood transfusion affects oncologic outcomes after nephrectomy for renal cell carcinoma: A systematic review and meta-analysis.
    Iwata T; Kimura S; Foerster B; Abufaraj M; Karakiewicz PI; Preisser F; Nasu Y; Shariat SF
    Urol Oncol; 2019 Apr; 37(4):273-281. PubMed ID: 30737159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
    Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
    World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors for perioperative blood transfusions in partial nephrectomy for renal masses.
    Abu-Ghanem Y; Dotan Z; Kaver I; Ramon J
    J Surg Oncol; 2015 Oct; 112(5):496-502. PubMed ID: 26437866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of perioperative blood transfusion on mortality for major urologic malignancies.
    Soubra A; Zabell JR; Adejoro O; Konety BR
    Clin Genitourin Cancer; 2015 Jun; 13(3):e173-81. PubMed ID: 25600760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a.
    Shah PH; Moreira DM; Patel VR; Gaunay G; George AK; Alom M; Kozel Z; Yaskiv O; Hall SJ; Schwartz MJ; Vira MA; Richstone L; Kavoussi LR
    J Urol; 2017 Aug; 198(2):289-296. PubMed ID: 28274620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M; Schubert T; Xylinas E; Kluth L; Rouprêt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF;
    Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term Outcomes of Intraoperative Cell Saver Transfusion During Open Partial Nephrectomy.
    Lyon TD; Ferroni MC; Turner RM; Jones C; Jacobs BL; Davies BJ
    Urology; 2015 Dec; 86(6):1153-8. PubMed ID: 26387849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.